Gender-specific effects of COVID-19 lockdowns on scientific publishing productivity: Impact and resilience.


Journal

Social science & medicine (1982)
ISSN: 1873-5347
Titre abrégé: Soc Sci Med
Pays: England
ID NLM: 8303205

Informations de publication

Date de publication:
03 2023
Historique:
received: 13 02 2022
revised: 31 01 2023
accepted: 02 02 2023
pubmed: 14 2 2023
medline: 3 3 2023
entrez: 13 2 2023
Statut: ppublish

Résumé

The SARS-CoV2 pandemic led to drastic social restrictions globally. Early data suggest that women in science have been more adversely affected by these lockdowns than men, with relatively fewer scientific articles authored by women. However, these observations test broad populations with many potential causes of disparity. Australia presents a natural experimental condition where several states of similar demographics and disease impact had differing approaches in their social isolation strategies. The state of Victoria experienced 280 days of lockdowns from 2020 to 2021, whereas the comparable state of New South Wales experienced 107 days, most of these in 2021, and other states even fewer restrictions. To assess how the gender balance changed in Australian biomedical publishing with the lockdowns, we created a custom workflow to analyse PubMed data from more than 120,000 published articles submitted in 2019-2021 from Australian authors. Broadly, Australian women have been incredibly resilient to the challenges faced by the lockdowns. There was an increase in the number of published articles submitted in 2020 that was equally due to women as men, including from Victoria. On the other hand, articles specifically addressing COVID-19 were significantly less likely to be authored by women than those on other topics, a finding not likely due to particular gender imbalance in virology or viral epidemiology, since publications on HIV followed similar patterns to previous years. By 2021, this imbalance had reversed, with more COVID-19-related papers authored by women than men. These data suggest women from Victoria were less able to rapidly transition to new research early in the pandemic but had accommodated to the new conditions by 2021. This work indicates we need strategies to support women in science as the pandemic continues and to continue to monitor the situation for its impact on vulnerable groups.

Identifiants

pubmed: 36780736
pii: S0277-9536(23)00118-1
doi: 10.1016/j.socscimed.2023.115761
pmc: PMC9896855
pii:
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

115761

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

M Ryan (M)

School of Mathematical Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia; Australian Research Council Centre of Excellence for Mathematical and Statistical Frontiers, Australia.

J Tuke (J)

School of Mathematical Sciences, University of Adelaide, Adelaide, South Australia, 5005, Australia; Australian Research Council Centre of Excellence for Mathematical and Statistical Frontiers, Australia.

M R Hutchinson (MR)

Adelaide Medical School, University of Adelaide, Adelaide, South Australia, 5005, Australia; Australian Research Council Centre of Excellence for Nanoscale BioPhotonics, Australia; Davies Livestock Research Centre, University of Adelaide, South Australia, 5005, Australia; Institute for Photonics & Advanced Sensing, University of Adelaide, South Australia, 5005, Australia; Robinson Research Institute, University of Adelaide, South Australia, 5005, Australia.

S J Spencer (SJ)

Australian Research Council Centre of Excellence for Nanoscale BioPhotonics, Australia; School of Health and Biomedical Sciences, RMIT University, Melbourne, Vic, 3083, Australia. Electronic address: Sarah.Spencer@rmit.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH